The Form 4 filing, an SEC report about an insider's stock activity, was submitted on November 17, 2026. The trades took place on November 16–17. Wupen Yuen is listed as president of global business units at Lumentum Holdings Inc. (LITE).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 1,000 |
| Price | $560.15 |
| Total Transaction Value | $560,155.00 |
| Insider | |
| Ticker Symbol | LITE |
| Company | Lumentum Holdings Inc. |
| Insider Name | Wupen Yuen |
| Insider Title | PRESIDENT, GLOBAL BUS. UNITS |
| Sector - Industry | Technology - Communication Equipment |
| Holdings | |
| Total Shares Owned After Transaction | 104,900 |
| Position Size Change | 0.94% |
| Filing | |
| Filing Date | 2026-11-17 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were stock sales, identified by transaction code S. The reported activity covers two transactions and 1,000 shares in total.
What was the average price of the transaction?
The reported average was $560.155 per share. The transaction table displays $560.15. Separate prices for each of the two sales are not available.
How did this transaction affect the insider's holdings?
He sold 1,000 shares and reported 104,900 shares owned afterward. The reported balance before the sales was 105,900 shares. The shares sold made up 0.94% of that earlier balance.
What's the total transaction value?
The total reported value was $560,155.00 across the two sales, covering all 1,000 shares sold.
Are there any special circumstances around this transaction?
The available details include a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance.
Footnote text is unavailable for this report, so it is unclear which sales the reference covers. The plan's start date and trade schedule are also unknown. The reference alone does not show whether the plan met the rule's legal requirements.
For research purposes only; not investment advice.